India CINV Existing and Pipeline Drugs Market (2025-2031) | Segmentation, Industry, Growth, Share, Companies, Size & Revenue, Trends, Value, Competitive Landscape, Analysis, Forecast, Outlook

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 India Country Macro Economic Indicators

3.2 India CINV Existing and Pipeline Drugs Market Revenues & Volume, 2021 & 2031F

3.3 India CINV Existing and Pipeline Drugs Market - Industry Life Cycle

3.4 India CINV Existing and Pipeline Drugs Market - Porter's Five Forces

3.5 India CINV Existing and Pipeline Drugs Market Revenues & Volume Share, By Major Drug, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chemotherapy-induced nausea and vomiting (CINV) cases in India

4.2.2 Growing awareness and adoption of CINV drugs among healthcare professionals and patients

4.2.3 Rising investments in research and development for new and improved CINV treatments

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug approvals in India

4.3.2 High competition among pharmaceutical companies in the CINV market

4.3.3 Challenges in pricing and reimbursement policies affecting market penetration

6.1 India CINV Existing and Pipeline Drugs Market, By Major Drug

6.1.1 Overview and Analysis

6.1.2 India CINV Existing and Pipeline Drugs Market Revenues & Volume, By Major Drug, 2021- 2031F

6.1.3 India CINV Existing and Pipeline Drugs Market Revenues & Volume, By Aloxi (Palonosetron), 2021- 2031F

6.1.4 India CINV Existing and Pipeline Drugs Market Revenues & Volume, By Zofran Generic (Ondansetron), 2021- 2031F

6.1.5 India CINV Existing and Pipeline Drugs Market Revenues & Volume, By Kytril Generic (Granisetron), 2021- 2031F

6.1.6 India CINV Existing and Pipeline Drugs Market Revenues & Volume, By Emend (Aprepitant), 2021- 2031F

6.1.7 India CINV Existing and Pipeline Drugs Market Revenues & Volume, By Akynzeo (Netupitant-Palonosetron), 2021- 2031F

6.1.8 India CINV Existing and Pipeline Drugs Market Revenues & Volume, By SUSTOL (Extended Release Granisetron Injection), 2021- 2031F

7.1 India CINV Existing and Pipeline Drugs Market Export to Major Countries

7.2 India CINV Existing and Pipeline Drugs Market Imports from Major Countries

8.1 Patient adherence rate to CINV medications

8.2 Number of clinical trials for new CINV drugs in India

8.3 Prescription rates of newer generation CINV drugs

8.4 Rate of adverse events reported for existing CINV drugs

8.5 Market penetration of CINV drugs in rural areas of India

9.1 India CINV Existing and Pipeline Drugs Market Opportunity Assessment, By Major Drug, 2021 & 2031F

10.1 India CINV Existing and Pipeline Drugs Market Revenue Share, By Companies, 2024

10.2 India CINV Existing and Pipeline Drugs Market Competitive Benchmarking, By Operating and Technical Parameters